Clinical Trial Update: Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma [NA]

View source ↗

Summary

Clinical trial update evaluating safety and efficacy of selective intra-arterial Holmium-166 radiation therapy in combination with atezolizumab and bevacizumab …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• QuiremSpheres (Holmium-166 microspheres)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Hepatocellular Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING